the large apple – ()–Massive Bio, a frontrunner in matching most cancers victims with medical trials using artificial intelligence (AI), is completely happy to announce that it has been named to New York’s Digital Nicely being 100 (DH100) for the second consecutive 12 months. I am honored. DH100, printed yearly by Digital Nicely being New York (DHNY), showcases the New York area’s most fulfilling and revolutionary nicely being startups, New York Healthcare Innovation Report 2023The report, now in its sixth model, explores the leaders, tendencies and information shaping healthcare innovation in New York. DHNY’s acknowledged goal is to “create a linked neighborhood that shares ideas, takes new directions, and builds success all through the healthcare ecosystem.”

Rivals for entry into this 12 months’s DH100 was fierce, with DHNY receiving double the number of entries compared with 2022. large scale bio was included on the file for the second 12 months in a row and was named one among many excessive 10 companies throughout the Information & Platforms: Analytics & Insights class.

“Massive Bio has been headquartered in New York Metropolis since its founding in 2015, so being chosen is crucial to us. Selin Kurnaz, co-founder and CEO of Massive Bio. “The medical ecosystem entails some very difficult and hard processes across the globe, nevertheless our journey, which began in New York Metropolis, has, in a quick time interval, unfold him to 12 nations and over 100,000 people. I reached a most cancers affected particular person.”

Massive Bio helps most cancers victims across the globe entry medical trials of revolutionary oncology cures and procure increased outcomes. The company’s AI-based know-how makes use of over 170 proprietary algorithms to match victims and medical trials across the globe with unmatched accuracy. Using NLP, computer imaginative and prescient and various kinds of AI, Massive Bio’s extracts information from affected particular person medical knowledge and identifies medical trial matches through a course of overseen by a licensed oncology case supervisor.

“Our platform is a software program for finding medical trials, a provide of hope and a beacon of progress throughout the battle in direction of most cancers,” Kurnaz talked about. “We think about artificial intelligence can rework healthcare and improve outcomes for many cancers victims, and our participation throughout the New York Digital Nicely being 100 is proof of that. It represents the intersection of know-how and humanity to help most cancers victims take administration of their nicely being journey through entry to medical trial information.”

He added that Massive Bio will proceed to innovate and develop AI capabilities. Arturo Loaisa Bonilla, MD, co-founder and chief medical officer of Massive Bio. “By developing these capabilities, each most cancers affected particular person will most likely be empowered to do what know-how is ready to and provide real-time information and insights. We’re devoted to developing the long term,” says Loaiza-Bonilla. “We envision a world the place victims can provide consideration to what points, their nicely being and well-being, with out the burden of navigating medical evaluation areas. It is our notion that the majority cancers victims deserve the possibility to find all potential remedy decisions, and our platform is devoted to creating that happen.”

About Massive Bio

Massive Bio helps most cancers victims uncover the proper remedy decisions, providing useful entry and registration suppliers to world oncology medical trials powered by superior artificial intelligence. Primarily based on the concept that everyone should have equal entry to cutting-edge cures, Massive Bio combines a best-in-class artificial intelligence platform with concierge-level suppliers to help most cancers victims enroll in medical trials. It removes a number of the obstacles you face when collaborating in Headquartered in New York Metropolis and with larger than 100,000 of his victims on its platform, Massive Bio operates in 12 nations.

It’s possible you’ll entry Massive Bio throughout the following strategies: 100KSINGULARITY@massivebio.com, twitter, LinkedInand Facebook.

By Editor

Leave a Reply